78
Participants
Start Date
April 1, 2021
Primary Completion Date
May 25, 2023
Study Completion Date
June 26, 2023
SAR443122
Pharmaceutical form: Capsule Route of administration: Oral
Placebo
Pharmaceutical form: Capsule Route of administration: Oral
Investigational Site Number : 3480001, Budapest
Investigational Site Number : 0360002, East Melbourne
Investigational Site Number : 0360001, Camberwell
Investigational Site Number : 3480002, Szeged
Investigational Site Number : 3800001, Genova
Investigational Site Number : 3800002, Milan
Investigational Site Number : 7240004, Madrid
DJL Clinical Research, PLLC Site Number : 8400003, Charlotte
Investigational Site Number : 4840004, Chihuahua City
GNP Research Site Number : 8400008, Cooper City
ClinOhio Research Services Site Number : 8400007, Columbus
Investigational Site Number : 2030006, Pardubice
Investigational Site Number : 4840001, Monterrey, Nuevo León
Investigational Site Number : 2030002, Brno
Investigational Site Number : 8040001, Ivano-Frankivsk
Prolato Clinical Research Center Site Number : 8400010, Houston
Investigational Site Number : 4840002, Veracruz
Investigational Site Number : 6430005, Moscow
Investigational Site Number : 6430002, Moscow
Investigational Site Number : 3560002, Chandigarh
Investigational Site Number : 6430001, Saint Petersburg
Investigational Site Number : 6430004, Krasnodar
Investigational Site Number : 6430003, Stavropol
Investigational Site Number : 3560004, Nashik
Investigational Site Number : 3560003, Nagpur
Investigational Site Number : 1520009, Valdivia
Investigational Site Number : 1520006, Osorno
Investigational Site Number : 1520007, Santiago
Investigational Site Number : 1520003, Santiago
Investigational Site Number : 1520001, Santiago
Investigational Site Number : 1520002, Santiago
Investigational Site Number : 0320002, CABA
Investigational Site Number : 0320003, CABA
Investigational Site Number : 0320001, CABA
Investigational Site Number : 0320004, Rosario
Investigational Site Number : 0320005, Mendoza
Investigational Site Number : 1240001, London
Investigational Site Number : 1240005, Toronto
Investigational Site Number : 1240002, Sherbrooke
Investigational Site Number : 2030004, Náchod
Investigational Site Number : 2030005, Prague
Investigational Site Number : 4840003, Benito Juárez
Investigational Site Number : 6160006, Krakow
Investigational Site Number : 6160004, Lublin
Investigational Site Number : 6160007, Katowice
Investigational Site Number : 7240002, Barcelona
Investigational Site Number : 7240007, Barcelona
Investigational Site Number : 7240001, L'Hospitalet de Llobregat
Investigational Site Number : 8040002, Kyiv
Investigational Site Number : 8260003, London
Lead Sponsor
Sanofi
INDUSTRY